TNGXTango Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · tangotx.com

23.88USD-5.24%Mkt Cap: 4.03B $P/E: —3d ago

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative prot…

Headline	Source	Time
Older
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses Tango Therapeutics stock falls 5% on a wider-than-expected Q2 loss, reflecting higher operating expenses, while pipeline progress remains in focus.	Zacks	Aug 12
How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48% The average of price targets set by Wall Street analysts indicates a potential upside of 49.5% in Tango Therapeutics (TNGX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.	Zacks	Jul 22
Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues Tango Therapeutics Inc. (NASDAQ:TNGX) is one of the 10 affordable biotech stocks to buy right now. On June 29, Canaccord Genuity increased its target price on Tango Therapeutics Inc. (NASDAQ:TNGX) from $42 to $46, resulting in more than 53% upside potential. The firm kept a Buy rating on the stock, highlighting further upside from vopimetostat + […]	IInsider Monkey	Jul 15
2 Monster Growth Stocks Analysts Think Can Reach New Highs	TipRanks	Jul 9
Tango Therapeutics Rides a New Precision Oncology Trend in 2026	Zacks	Jul 2
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?	Zacks	Jul 2
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts	Zacks	Jul 2
This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In.	Barrons.com	Jun 26
Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD	Simply Wall St.	Jun 12
Imviva Unveils Leukemia Data at EHA 2026 With 86% Response Rates	Exec Edge	Jun 11
Is Tango Therapeutics (TNGX) Price Justified After Its 7x Surge In One Year	Simply Wall St.	Jun 10
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results	Zacks	Jun 9
Tango Therapeutics stock surges on pancreatic cancer trial data	Quartz	Jun 9
Tango Therapeutics (TNGX) Stock Soars on Pancreatic Cancer Trial Results	Barchart	Jun 9
Tango Therapeutics Stock Soars 53% After ’Unprecedented’ Data on Pancreatic Cancer Treatment	Barrons.com	Jun 8
Tango Skyrockets On Eye-Popping Pancreatic Cancer Results	Investor's Business Daily	Jun 8
Sector Update: Healthcare Stocks Decline Late Afternoon	MMT Newswires	Jun 8
🔎 Under the Radar: Tango Stock Climbs on Positive Pancreatic Cancer Data	The Wall Street Journal	Jun 8
Top Midday Gainers	MMT Newswires	Jun 8
TNGX Stock Hits All-Time High – Wolfe Research Calls Tango Therapeutic’s Pancreatic Cancer Trial Data ‘Groundbreaking’	Stocktwits	Jun 8
Top Midday Stories: US Weighs Financial Stakes in AI Firms; Google, Nvidia Turn to Intel as TSMC Struggles With Demand	MMT Newswires	Jun 8
Tango Therapeutics Says Initial Results From Phase 1/2 Trial of Pancreatic Cancer Drug Candidate Showed Improvement in Survival Rate; Shares Rise Pre-Bell	MMT Newswires	Jun 8
Tango Therapeutics (TNGX) Could Benefit From Pancreatic Ductal Adenocarcinoma Data Announcement	IInsider Monkey	Jun 5
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20	IInsider Monkey	Jun 3
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More	Motley Fool	May 30
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1	Motley Fool	May 27

TNGXTango Therapeutics Inc.

Industry Peers